Can Medicaid Managed Care mitigate race/ethnic health disparities in diabetes?
医疗补助管理式医疗能否减轻糖尿病中的种族/民族健康差异?
基本信息
- 批准号:10528738
- 负责人:
- 金额:$ 52.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-23 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdmission activityAdultAffectAgeAmericanAmericasAmputationBehaviorBlack raceCOVID-19COVID-19 pandemicCOVID-19 pandemic effectsCaringCharacteristicsChronic DiseaseCommunitiesContractsDataData AnalysesData SetDatabasesDiabetes MellitusDiagnosisDistrict of ColumbiaEconomic BurdenEligibility DeterminationEmergency department visitEnrollmentEthnic OriginExpenditureFloridaFutureGoalsHealth Care CostsHeterogeneityHospitalizationHyperglycemiaIncentivesIndigenousInformation SystemsInsurance CarriersInterviewInvestigationKentuckyLatinxLawyersLinkManaged CareManaged Care ProgramsMedicaidMedicare/MedicaidMethodsMinorityNational Institute on Minority Health and Health DisparitiesNon-Insulin-Dependent Diabetes MellitusObesityOccupationsOutcomePatientsPenetrationPerformancePersonsPharmaceutical PreparationsPoliciesPopulationPovertyPreventive carePrimary Health CarePrivatizationProcessQuality of CareRaceResearchRiskSamplingSelection BiasServicesShockTestingTimeTitrationsVariantVulnerable PopulationsWorkbasebeneficiaryblack patientburden of illnesscare outcomescohortcomorbiditycoronavirus diseasecostdata modelingdesigndisenfranchised populationdisparity reductionethnic disparityethnic health disparityethnic minorityevidence baseexperiencefamily burdenfoothealth disparityhigh riskimprovedinsightmedical specialtiesmemberpandemic diseasepeople of colorpost-COVID-19programsresponseservice utilizationsexsocioeconomic disadvantagetrend
项目摘要
ABSTRACT
This study represents a timely investigation that addresses race/ethnic disparities in type 2 diabetes (T2DM)
care over a period that included a major pandemic shock. T2DM is burdensome and disproportionately impacts
vulnerable and disenfranchised populations; of note, there are stark race/ethnic disparities in T2DM care goals,
emergency department (ED) visits, and hospitalizations. Medicaid covers 25% of Americans with T2DM. More
than 80% of Medicaid beneficiaries nationally receive at least some of their care from Medicaid managed care
organizations (MMCO). States contract with private (non-profit or for-profit) MMCOs to lower costs, increase
quality, and pass on financial risks of covering Medicaid beneficiaries. Heterogeneity across and within state
programs can have implications for quality of T2DM care and, specifically, race/ethnic disparities through
benefit generosity or by affecting MMCO entry and post-entry behavior. State policymakers also have
significant influence over marketplaces in which MMCOs compete, which can have consequences for
race/ethnic disparities, given that Medicaid disproportionately covers non-white populations. Little is known
about whether and how MMCOs and the state programs they operate in influence disparities in T2DM care
and, if or how the COVID-19 pandemic changed the trajectory of health disparities. We propose to answer
these unknowns using a convergent mixed-methods study: we will compile a database of MMCO/state
program features that could influence care using a health disparities conceptual framework (Aim 1); we will
empirically explore race/ethnic disparities among adults with T2DM and whether these vary by MMCO/state
features and pre-/post-COVID-19 using comprehensive data from the Transformed Medicaid Statistical
Information System over 2016-2025 (Aims 2 and 3); and we will collect and analyze qualitative data from
Medicaid stakeholders to triangulate and contextualize the quantitative findings (Aim 4). We focus on non-
disabled, non-pregnant 18-64-year-old adults with T2DM who tend to remain stably covered by Medicaid over
time. To reduce selection bias, we focus our analyses on 12 states and the District of Columbia that mandate
enrollment in comprehensive MMCOs. We will use panel data models to examine race/ethnic and sex-specific
receipt of key T2DM services and ED visits and hospitalizations, overall and by MMCO/state features. We will
also follow a continuously enrolled cohort over 2020-2025 to assess if and how MMCO/state program features
moderate the pandemic’s effects on T2DM disparities. Sensitivity analyses will explore the influence of churn.
Further, our preliminary analyses identify Kentucky and Florida as having the lowest and highest disparities in
T2DM care, respectively; we will conduct interviews in these states to examine what MMCO/state features and
implementation might explain these disparities. This policy-relevant work will provide critical insights into how
Medicaid managed care programs can be designed to reduce disparities in chronic disease burdens.
摘要
这项研究是一项针对2型糖尿病(T2 DM)种族/民族差异的及时调查
在包括重大大流行休克在内的一段时间内提供护理。T2 DM负担沉重,影响不成比例
弱势和被剥夺公民权的人群;值得注意的是,在T2 DM护理目标方面存在明显的种族/民族差异,
急诊科就诊和住院治疗。医疗补助覆盖了25%患有T2 DM的美国人。更多
全国超过80%的医疗补助受益人至少从医疗补助管理的医疗保健中获得部分护理
组织(MMCO)。各州与私营(非营利性或营利性)MMCO签订合同,以降低成本,增加
质量,并转嫁覆盖医疗补助受益人的财务风险。跨州和州内的异质性
这些计划可能会对T2 DM的护理质量产生影响,特别是通过以下方式影响种族/民族差异
通过慷慨或通过影响MMCO进入和进入后的行为来受益。州政府政策制定者也有
对MMCO竞争的市场产生重大影响,这可能会对
种族/民族差异,因为医疗补助不成比例地覆盖了非白人人口。鲜为人知
关于MMCO及其运营的国家项目是否以及如何影响T2 DM医疗保健方面的差异
以及,新冠肺炎大流行是否或如何改变健康差距的轨迹。我们建议回答
使用收敛的混合方法研究这些未知数:我们将编制一个MMCO/STATE数据库
使用健康差距概念框架(目标1)可能影响护理的方案特点;我们将
经验性地探讨成年T2 DM患者的种族/民族差异,以及这些差异是否因MMCO/州而异
使用转换后的医疗补助统计数据的功能和新冠肺炎前后的综合数据
2016-2025年的信息系统(目标2和目标3);我们将从以下方面收集和分析定性数据
医疗补助利益攸关方对量化结果进行三角测量和背景分析(目标4)。我们专注于非
残疾、未怀孕的-18岁患有T2 DM的成年人,往往保持稳定的医疗补助覆盖范围
时间到了。为了减少选择偏差,我们将分析重点放在12个州和哥伦比亚特区
参加综合性的MMCO课程。我们将使用面板数据模型来检查种族/民族和特定性别
接受关键的T2 DM服务以及急诊科就诊和住院治疗,总体上和按MMCO/州功能划分。我们会
我还关注2020-2025年持续登记的队列,以评估MMCO/州计划是否以及如何发挥作用
缓和大流行对2型糖尿病差异的影响。敏感度分析将探索员工流失的影响。
此外,我们的初步分析发现,肯塔基州和佛罗里达州在
我们将在这些州进行访谈,以检查MMCO/州的哪些特征和
实施或许可以解释这些差异。这项与政策相关的工作将为以下方面提供关键的见解
医疗补助管理保健计划可以设计为减少慢性病负担方面的差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mohammed Kumail Ali其他文献
Mohammed Kumail Ali的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mohammed Kumail Ali', 18)}}的其他基金
Training on ImplemenTAtioN and team Science for NCD Control (TITANS) program
非传染性疾病控制 (TITANS) 计划的实施和团队科学培训
- 批准号:
10665456 - 财政年份:2023
- 资助金额:
$ 52.59万 - 项目类别:
Enhanced BReast and cErvical cAncer screening in Kenya THROUGH implementation science research and training (The BREAKTHROUGH Center)
通过实施科学研究和培训,肯尼亚加强了乳腺癌和宫颈癌筛查(突破中心)
- 批准号:
10738131 - 财政年份:2023
- 资助金额:
$ 52.59万 - 项目类别:
Can Medicaid Managed Care mitigate race/ethnic health disparities in diabetes?
医疗补助管理式医疗能否减轻糖尿病中的种族/民族健康差异?
- 批准号:
10709582 - 财政年份:2022
- 资助金额:
$ 52.59万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10508822 - 财政年份:2020
- 资助金额:
$ 52.59万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10841100 - 财政年份:2020
- 资助金额:
$ 52.59万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10705125 - 财政年份:2020
- 资助金额:
$ 52.59万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10267701 - 财政年份:2020
- 资助金额:
$ 52.59万 - 项目类别:
COllaborative research, implementation, And LEadership training to addresS chronic Conditions across the lifecoursE (COALESCE)
协作研究、实施和领导力培训,以解决整个生命周期的慢性病(COALESCE)
- 批准号:
10210320 - 财政年份:2019
- 资助金额:
$ 52.59万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 52.59万 - 项目类别:
Standard Grant